Comparison of Access Site Complications after Early or Late Sheath Removal in Patients with PCI, Regardless of ACT Levels

dc.contributor.authorÖzyurtlu F.
dc.contributor.authorÖzdemir İ.H.
dc.contributor.authorÇetin N.
dc.contributor.authorYavuz V.
dc.date.accessioned2024-07-22T08:04:16Z
dc.date.available2024-07-22T08:04:16Z
dc.date.issued2022
dc.description.abstractBackground: Despite the lack of supporting data, many clinics perform sheath removal 4-6 hours after femoral percutaneous coronary intervention to reduce the risk of possible access site complications. This study aims to examine the effects of sheath removal immediately after the procedure on access site complications and patient comfort. Methods: This prospective study included 349 patients who underwent percutaneous coronary intervention via the femoral site and 6 French guiding catheters. The sheath in the early group was removed immediately after the procedure without checking the activated clotting time levels but after 4 hours in the late group. Access site complications were recorded and patient comfort was evaluated using the Visual Analog Scale. Results: Patients were divided into 2 groups: patients in the early removal group (n = 171) and in the late removal group (n = 178). There was no statistically significant difference between the 2 groups in terms of access site complications. Three patients in the early removal group and 4 patients in the late removal group developed a hematoma. Six patients in the early removal group and 10 patients in the late removal group showed ecchymosis. The Visual Analog Scale score was statistically significantly lower in the early removal group compared with that in the late removal group [2 (1-3) vs. 3 (2-4), P < .001]. Conclusion: This study shows that immediate sheath removal is safe and more comfortable for patients with percutaneous coronary intervention who received weight-adjusted dose of heparin, regardless of the percutaneous coronary intervention levels after the procedure. Copyright@Author(s)
dc.identifier.DOI-ID10.5152/AnatolJCardiol.2022.1733
dc.identifier.issn21492263
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12637
dc.language.isoEnglish
dc.publisherTurkish Society of Cardiology
dc.rightsAll Open Access; Gold Open Access
dc.subjectAngioplasty, Balloon, Coronary
dc.subjectFemoral Artery
dc.subjectHeparin
dc.subjectHumans
dc.subjectPercutaneous Coronary Intervention
dc.subjectProspective Studies
dc.subjectTreatment Outcome
dc.subjectacetylsalicylic acid
dc.subjectclopidogrel
dc.subjectcreatinine
dc.subjectticagrelor
dc.subjectheparin
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectbackache
dc.subjectbleeding
dc.subjectcontrolled study
dc.subjectcoronary artery disease
dc.subjectdiabetes mellitus
dc.subjectecchymosis
dc.subjectechography
dc.subjectfalse aneurysm
dc.subjecthematoma
dc.subjecthuman
dc.subjecthyperlipidemia
dc.subjecthypertension
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectpercutaneous coronary intervention
dc.subjectperipheral ischemia
dc.subjectretroperitoneal hematoma
dc.subjectsheath removal
dc.subjectvisual analog scale
dc.subjectadverse event
dc.subjectfemoral artery
dc.subjectprospective study
dc.subjectsurgery
dc.subjecttransluminal coronary angioplasty
dc.subjecttreatment outcome
dc.titleComparison of Access Site Complications after Early or Late Sheath Removal in Patients with PCI, Regardless of ACT Levels
dc.typeArticle

Files